Please login to the form below

Not currently logged in
Email:
Password:

acne

This page shows the latest acne news and features for those working in and with pharma, biotech and healthcare.

Bayer extends alliance with Evotec in women’s health

Bayer extends alliance with Evotec in women’s health

It’s caused by the production of higher than usual levels of male hormones and aside from fertility issues can also lead to obesity, hair loss and acne, as well as

Latest news

  • Realm toppled by second mid-stage trial flop Realm toppled by second mid-stage trial flop

    We are conducting a full review to determine whether there is a path forward for our proprietary technology in atopic dermatitis, and to evaluate the implications for our acne and psoriasis ... programmes.”. Both of those are still in preclinical

  • Almirall acquires Allergan’s dermatology portfolio for $650m Almirall acquires Allergan’s dermatology portfolio for $650m

    years. This particular treatment is aimed to treat moderate-to-severe acne vulgaris in patients aged nine years and older and is scheduled for FDA evaluation later this year. ... Almirall will also adopt a further four already-marketed products,

  • Novartis pushes ‘virtual’ clinical trial concept Novartis pushes ‘virtual’ clinical trial concept

    It’s already running semi-virtual trials for non-alcoholic steatohepatitis (NASH), acne and cluster headache.

  • Dermira craters as acne drug fails late-stage test Dermira craters as acne drug fails late-stage test

    Dermira’s acne candidate DRM01 failed to hit the mark in two phase III trials and this has left the company with a big hole in its pipeline that could take ... The topical drug, which acts to inhibit sebum production in the skin by blocking acetyl

  • J&J launches digital skincare challenge J&J launches digital skincare challenge

    Technology that increases efficacy for topical applications in hard-to-treat areas such as acne and eczema and ‘insights-generating tools’ to help consumers with their skincare choices cover the

More from news
Approximately 4 fully matching, plus 71 partially matching documents found.

Latest Intelligence

  • Embracing digital disruption in pharma Embracing digital disruption in pharma

    HelloSkin is the number one online store for emollients, nutrition supplements, accessories and selected over-the-counter products for people living with psoriasis, eczema, acne and dry skin.

  • Communicating health messages Communicating health messages

    For instance: 'Say hello to clear skin and goodbye to acne without any irritation.'.

  • Deal Watch November 2015 Deal Watch November 2015

    The deal includes Protopic (tacrolimus) for severe eczema treatment, skin creams Locoid and Locobase and acne therapy Zineryt (erythromycin/zinc acetate).

  • Pharma deals during November 2012 Pharma deals during November 2012

    The key prizes: DUSA's FDA approved Levulan combination therapy, used to treat non-hyperkeratotic actinic keratosis of the face or scalp, and BLU-U, used to treat moderate inflammatory acne ... 255. DUSA / Sun Pharma. Acquisition. Levulan to treat

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics